Want to thrive in an AI-first world? Our FREE Survival Skills Series gives you new tools to add to your kit.

AI is already reshaping hiring and talent development. Download the State of Tech Talent 2026 for global insights on what's working.



    Begin your learning Pathway

    AI Fundamentals

    Take individual courses or combine them to build end-to-end AI capability for the modern workplace.



    Begin your learning Pathway

    AI Data Analytics

    Take individual courses or combine them to master the tools and methodologies that power modern AI data analytics.



    Begin your learning Pathway

    AI & Machine Learning

    Take individual courses or combine them to master the tools and methodologies that power production-grade AI applications.



    Begin your learning Pathway

    AI Product Management

    Take individual courses or combine them to master the frameworks and methodologies that power successful AI-driven products.



    Begin your learning Pathway

    AI Software Engineering

    Take individual courses or combine them to master the complete AI software engineering stack.



    Begin your learning Pathway

    AI Experience & Design

    Take individual courses or combine them to master the tools and methodologies that power modern AI product design.

    Get More Info
    Garry Cooper, Jr., PhD Photo

    Garry Cooper, Jr., PhD

    CEO & Co-Founder, Rheaply

    Chicago

    Dr. Garry Cooper is the CEO/Co-founder of Rheaply, Inc. Dr. Cooper is also a Scholar at Google for Entrepreneurs and an Adj. Assistant Professor at Northwestern University’s Department of Physiology. Before Rheaply, Inc., Dr. Cooper was a Senior Consultant at Ernst & Young, LLP in the Life Science Advisory practice where he worked in performance improvement and supply chain for pharmaceutical clients. Before joining Ernst & Young and his current position in the physiology department at the Feinberg School of Medicine and X, Dr. Cooper was a postdoctoral fellow at Northwestern University in the department of physiology at the Feinberg School of Medicine, where he worked with Profs. Richard Silverman, Eric Weiss, and D. James Surmeier in furthering efforts to develop and identify a therapeutic measure to slow the progression of Parkinson’s disease. Before his postdoctoral training, Dr. Cooper was a consultant at Promidian Consulting, a NY-based pharmaceutical consulting firm. In Promidian’s Chicago office, Dr. Cooper worked on projects concerning late-stage clinical trial/pre-market launch strategy. Before joining Promidian, Dr. Cooper worked on drug development for Parkinson’s disease at Northwestern University. Much of this work was done while completing his PhD in neuroscience at Northwestern University under the supervision of Richard B. Silverman (inventor of Lyrica®) and D. James Surmeier. While at Northwestern University, Dr. Cooper received several awards for scientific merit and presentation, published in high-impacting peer-reviewed international journals (i.e., Nature Communication), and participated in a drug development effort that led to a US patent. Before coming to Northwestern, Dr. Cooper worked in the department of chemistry at Indiana University where he facilitated the organic teaching laboratories. Prior to joining the chemistry department, Dr. Cooper was a student at Indiana University completing a Bachelor’s of Science in Mathematics and a Bachelor’s of Arts in Chemistry.

    Coming up near you

    Want to teach at ga?

    Join our global community of instructors and help shape the next generation of industry leaders — while moving your own career forward with proven subject matter expertise, leadership experience, and public speaking skills. Teach online or on campus, full-time
or part-time.

    Learn More